The DOI matches its Crossref record.
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo
Abstract
The voltage activated K+ channel (Kv1.3) has recently been identified as the molecule that sets the resting membrane potential of peripheral human T lymphoid cells. In vitro studies indicate that blockage of Kv1.3 inhibits T cell activation, suggesting that Kv1.3 may be a target for immunosuppression. However, despite the in vitro evidence, there has been no in vivo demonstration that blockade of Kv1.3 will attenuate an immune response. The difficulty is due to species differences, as the channel does not set the membrane potential in rodent peripheral T cells. In this study, we show that the channel is present on peripheral T cells of miniswine. Using the peptidyl Kv1.3 inhibitor, margatoxin, we demonstrate that Kv1.3 also regulates the resting membrane potential, and that blockade of Kv1.3 inhibits, in vivo, both a delayed-type hypersensitivity reaction and an Ab response to an allogeneic challenge. In addition, prolonged Kv1.3 blockade causes reduced thymic cellularity and inhibits the thymic development of T cell subsets. These results provide in vivo evidence that Kv1.3 is a novel target for immunomodulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
“However, in vivo evidence to support such a function is missing as mouse T cells do not express this channel (65).”
BackgroundWei, A. D., Gutman, G. A., Aldrich, R., Chandy, K. G., Grissmer, S., & Wulff, H. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.9 · Cited by 978
Calcium signaling mechanisms in T lymphocytes.
Lewis, R. S. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.497 · Cited by 860
Voltage-gated potassium channels as therapeutic targets
Wulff, H., Castle, N. A., & Pardo, L. A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2983 · Cited by 799
Therapeutic potential of venom peptides
Lewis, R. J., & Garcia, M. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1197 · Cited by 798
Self-citationIon Channels in Innate and Adaptive Immunity
Feske, S., Wulff, H., & Skolnik, E. Y. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112212 · Cited by 768
The functional network of ion channels in T lymphocytes
Cahalan, M. D., & Chandy, K. G. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00816.x · Cited by 599
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Beeton, C., Wulff, H., Standifer, N. E., Azam, P., Mullen, K. M., Pennington, M. W., Kolski-Andreaco, A., Wei, E., Grino, A., Counts, D. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605136103 · Cited by 538
Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities
Shieh, C.-C., Coghlan, M., Sullivan, J. P., & Gopalakrishnan, M. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01469-8 · Cited by 518
K+ channels as targets for specific immunomodulation
George Chandy, K., Wulff, H., Beeton, C., Pennington, M., Gutman, G. A., & Cahalan, M. D. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.010 · Cited by 427
The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS
Wulff, H., Calabresi, P. A., Allie, R., Yun, S., Pennington, M., Beeton, C., & Chandy, K. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16921 · Cited by 422
Up-regulation of the IKCa1 Potassium Channel during T-cell Activation
Ghanshani, S., Wulff, H., Miller, M. J., Rohm, H., Neben, A., Gutman, G. A., Cahalan, M. D., & Chandy, K. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003941200 · Cited by 406
Scorpion venom components as potential candidates for drug development
Ortiz, E., Gurrola, G. B., Schwartz, E. F., & Possani, L. D. (2015) · Toxicon · doi:10.1016/j.toxicon.2014.11.233 · Cited by 335
Beeton, C., Wulff, H., Barbaria, J., Clot-Faybesse, O., Pennington, M., Bernard, D., Cahalan, M. D., Chandy, K. G., & Béraud, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241497298 · Cited by 318
Bioenergetics of immune functions: fundamental and therapeutic aspects
Buttgereit, F., Burmester, G.-R., & Brand, M. D. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01593-0 · Cited by 282
Peptide therapeutics from venom: Current status and potential
Pennington, M. W., Czerwinski, A., & Norton, R. S. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.09.029 · Cited by 278
Judge, S. I. V., & Bever, C. T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.006 · Cited by 268
ShK-Dap22, a Potent Kv1.3-specific Immunosuppressive Polypeptide
Kalman, K., Pennington, M. W., Lanigan, M. D., Nguyen, A., Rauer, H., Mahnir, V., Paschetto, K., Kem, W. R., Grissmer, S., Gutman, G. A., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32697 · Cited by 256
Microglia Kv1.3 Channels Contribute to Their Ability to Kill Neurons
Fordyce, C. B., Jagasia, R., Zhu, X., & Schlichter, L. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1251-05.2005 · Cited by 213
Ehring, G. R., Kerschbaum, H. H., Eder, C., Neben, A. L., Fanger, C. M., Khoury, R. M., Negulescu, P. A., & Cahalan, M. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1593 · Cited by 163
Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease
McAninch, E. A., Fonseca, T. L., Poggioli, R., Panos, A. L., Salerno, T. A., Deng, Y., Li, Y., Bianco, A. C., & Iacobellis, G. (2015) · Obesity · doi:10.1002/oby.21059 · Cited by 130
“of effector memory T cells (27); this gene is also involved in glucose”
Tarcha, E. J., Chi, V., Muñoz-Elías, E. J., Bailey, D., Londono, L. M., Upadhyay, S. K., Norton, K., Banks, A., Tjong, I., Nguyen, H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.191890 · Cited by 117
Kv1.3 potassium channels as a therapeutic target in multiple sclerosis
Rangaraju, S., Chi, V., Pennington, M. W., & Chandy, K. G. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903018957 · Cited by 99
“3 inhibitors suppress the DTH response in mini-pigs (margatoxin) [87] and rats (kaliotoxin, ShK, ShK-170, ShK-186, ShK-192, correolide, Psora-4, PAP-1) [24,28,30,88,100,106,109,115].”
BackgroundBeeton, C., Wulff, H., Singh, S., Botsko, S., Crossley, G., Gutman, G. A., Cahalan, M. D., Pennington, M., & Chandy, K. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212868200 · Cited by 90
Metadata
- Authors
- Koo, G. C., Blake, J. T., Talento, A., Nguyen, M., Lin, S., Sirotina, A., Shah, K., Mulvany, K., Hora, D., Cunningham, P., Wunderler, D. L., McManus, O. B., Slaughter, R., Bugianesi, R., Felix, J., Garcia, M., Williamson, J., Kaczorowski, G., Sigal, N. H., Springer, M. S., & Feeney, W.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-06-01
- Volume
- 158
- Issue
- 11
- Pages
- 5120-5128
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1910853730
- Cited by
- 219
- References
- 0
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.